BioHarvest Sciences (TSE:BHSC) has released an update.
BioHarvest Sciences has announced a record third-quarter revenue of at least $6.5 million for 2024, marking a 100% increase from the previous year. The company is also aiming for a strong fourth quarter with projected revenues of $7.2 million, bolstered by new product launches and growing subscriptions. BioHarvest is on track to complete its Nasdaq uplisting by the end of the year.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
